Integrate insights from the patient-centered market report into business plan and pitch deck, incorporating findings on patient priorities, pMHC market dynamics, and regulatory strategies to strengthen deliverables.

This session aimed to integrate findings from a patient-centered market report — covering patient priorities, pMHC market dynamics, and regulatory strategy — into the business plan and pitch deck for the EoE-focused protein therapeutics project.

The agent revised deliverables to reflect the market report's insights, producing updated business and scientific plans along with supporting figures (patient priorities, payer value, market whitespace, scientific roadmap). It also corrected and verified functionality of the pitch deck, including fixing an earlier incorrect claim about hyperlinks — the deck's contact and hackathon links (email, LLC site, LinkedIn, hackathon page) were confirmed working at the XML level across title and closing slides. A number reconciliation file was also produced, suggesting an effort to check consistency of figures across documents.

The primary deliverable is Project_Tolera_Roadmap.pptx, a 16-slide deck with verified working hyperlinks, alongside business_plan.pdf and scientific_plan.pdf (with markdown source versions) and supporting figure images. An older deck, Tolera_Bio_VC_Pitch_Deck_v2.pptx, remains in the project as a superseded artifact pending a decision on removal.